Ira Blaufarb is a Cardiology physician affiliated with Mount Sinai Hospital. OpenAlex indexes 6 publications with 396 citations (h-index 5).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
177 East 87th Street
Suite 507
New York, NY 10128
Telephone
212-828-3200Registry record last updated 10 Sept 2012.
Industry payments
4 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- E.R. Squibb & Sons, L.L.C.Program year20254 payments
- Philips North America LLCProgram year20251 payment
- E.R. Squibb & Sons, L.L.C.Program year20242 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
83.9%Statin23.1%Rosuvastatin Calcium47%Atorvastatin Calcium37%Simvastatin11%Pravastatin Sodium7%Part D≥221 patientsBeta blocker11.9%Metoprolol Succinate68%Atenolol14%Carvedilol10%Metoprolol Tartrate7%Nebivolol Hcl1%Part D<11 patients+ 19 more classes in this area
Blood & clotting
8.5%Factor Xa inhibitor6.5%Eliquis89%Xarelto11%Part D≥89 patientsP2Y12 inhibitor1.7%Clopidogrel89%Brilinta11%Part D<11 patients+ 1 more class in this area
Metabolism & gastrointestinal
5.6%SGLT2 inhibitor3.3%Farxiga61%Jardiance39%Part D≥41 patientsProton pump inhibitor1.1%Pantoprazole Sodium73%Omeprazole27%Part D<11 patients+ 4 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Clinical benefits of long-term angiotensin II receptor blockade in patients with severe symptoms of congestive heart failure despite full angiotensin converting enzyme inhibition
Journal of the American College of Cardiology
1998 - Angiotensin II-Receptor Blockade Further Reduces Afterload Safely in Patients Maximally Treated with Angiotensin-Converting Enzyme Inhibitors for Heart Failure
Journal of Cardiovascular Pharmacology
1997
Similar KOLs
Other experts from the same institution or the same specialty.
Allison McGeer
Mount Sinai Hospital
Scott Sicherer, MD
Mount Sinai Hospital
Ulrich Specks
Mount Sinai Hospital
Jorge Sánchez‐Guerrero
Mount Sinai Hospital
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”